{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:13:26Z","timestamp":1784333606578,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014421","name":"EA Pharma Co., Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.lfs.2020.118048","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T11:48:52Z","timestamp":1593690532000},"page":"118048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Preventive effects of naldemedine, peripherally acting \u03bc-opioid receptor antagonist, on morphine-induced nausea and vomiting in ferrets"],"prefix":"10.1016","volume":"257","author":[{"given":"Toshiyuki","family":"Kanemasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanobu","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118048_bb0005","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Phys."},{"key":"10.1016\/j.lfs.2020.118048_bb0010","first-page":"1347","article-title":"Management of common opioid-induced adverse-effects","volume":"74","author":"Swegle","year":"2006","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.lfs.2020.118048_bb0015","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","article-title":"Opioids in chronic non-cancer pain: systematic review of efficacy and safety","volume":"112","author":"Kalso","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2020.118048_bb0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1634\/theoncologist.2017-0225","article-title":"Efficacy of prophylactic treatment for oxycodone-induced nausea and vomiting among patients with cancer pain (POINT): a randomized, placebo-controlled, double-blind trial","volume":"23","author":"Tsukuura","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.lfs.2020.118048_bb0025","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jpain.2010.02.007","article-title":"Importance of side effects in opioid treatment: a trade-off analysis with patients and physicians","volume":"11","author":"Gregorian","year":"2010","journal-title":"J. Pain"},{"key":"10.1016\/j.lfs.2020.118048_bb0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1089\/jpm.2018.0260","article-title":"The management of opioid-induced nausea and vomiting in patients with cancer: a systematic review","volume":"22","author":"Sande","year":"2019","journal-title":"J. Palliat. Med."},{"key":"10.1016\/j.lfs.2020.118048_bb0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jneuroim.2014.12.013","article-title":"Astrocytic TLR4 expression and LPS-induced nuclear translocation of STAT3 in the sensory circumventricular organs of adult mouse brain","volume":"278","author":"Nakano","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.lfs.2020.118048_bb0040","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.lfs.2018.07.028","article-title":"Pharmacological profile of TAN-452, a novel peripherally acting opioid receptor antagonist for the treatment of opioid-induced bowel","volume":"215","author":"Suzuki","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2020.118048_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13563","article-title":"Pharmacologic effects of naldemedine, a peripherally acting \u03bc-opioid receptor antagonist, in in vitro and in vivo models of opioid-induced constipation","author":"Kanemasa","year":"2019","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.lfs.2020.118048_bb0050","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1124\/jpet.119.264515","article-title":"Pharmacological profile of naldemedine, a peripherally acting \u03bc-opioid receptor antagonist: comparison with naloxone and naloxegol","volume":"373","author":"Kanemasa","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2020.118048_bb0055","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.dmpk.2018.12.002","article-title":"Minimal contribution of P-gp on the low brain distribution of naldemedine, a peripherally acting \u03bc-opioid receptor antagonist","volume":"34","author":"Watari","year":"2019","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.lfs.2020.118048_bb0060","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s40265-019-01160-7","article-title":"Naldemedine: a review in opioid-induced constipation","volume":"79","author":"Blair","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.lfs.2020.118048_bb0065","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1200\/JCO.2017.73.0853","article-title":"Randomized phase III and extension studies of naldemedine in patients with opioid-induced constipation and cancer","volume":"35","author":"Katakami","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2020.118048_bb0070","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1526-4637.2009.00583.x","article-title":"Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options","volume":"10","author":"Porreca","year":"2009","journal-title":"Pain Med."},{"key":"10.1016\/j.lfs.2020.118048_bb0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.gastro.2018.07.016","article-title":"American Gastroenterological Association Institute guideline on the medical management of opioid-induced constipation","volume":"156","author":"Crockett","year":"2019","journal-title":"Gastroenterology"},{"issue":"Suppl. 2","key":"10.1016\/j.lfs.2020.118048_bb0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1743-3150.2004.00554.x","article-title":"Function of opioids in the enteric nervous system","author":"Wood","year":"2004","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.lfs.2020.118048_bb0085","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0301-0082(89)90028-2","article-title":"Area postrema: chemoreceptor circumventricular organ of the medulla oblongata","volume":"32","author":"Borison","year":"1989","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.lfs.2020.118048_bb0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0166-4328(84)90220-1","article-title":"Peptide-induced emesis in dogs","volume":"11","author":"Carpente","year":"1984","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.lfs.2020.118048_bb0095","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0028-3908(92)90034-M","article-title":"The neuropharmacology of loperamide-induced emesis in the ferret: the role of the area, postrema, vagus, opiate and 5-HT3 receptors","volume":"31","author":"Bhandari P","year":"1992","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2020.118048_bb0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1254\/jjp.63.235","article-title":"Effect of naloxone on the morphine concentration in the central nervous system and plasma in rats","volume":"63","author":"Miyamoto","year":"1993","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118048_bb0105","author":"European Medicines Agency"},{"key":"10.1016\/j.lfs.2020.118048_bb0110","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","article-title":"CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice","volume":"22","author":"Thompson","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2020.118048_bb0115","first-page":"1083","article-title":"A preliminary study of the effect of naldemedine tosylate on opioid-induced nausea and vomiting","volume":"28","author":"Sato","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.lfs.2020.118048_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217371","article-title":"Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids","volume":"14","author":"Olson","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118048_bb0125","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0196-9781(99)00075-3","article-title":"Electron microscopic observation of mu-opioid receptor in the rat area postrema","volume":"20","author":"Guan","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.lfs.2020.118048_bb0130","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0196-9781(97)00234-9","article-title":"Electron microscopic observation of delta-opioid receptor-1 in the rat area postrema","volume":"18","author":"Guan","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.lfs.2020.118048_bb0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2013.09.074","article-title":"Opioid induced nausea and vomiting","volume":"722","author":"Smith","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118048_bb0140","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1177\/009127009803801105","article-title":"Effects of low-dose morphine on gastric emptying in healthy volunteers","volume":"38","author":"Yuan","year":"1998","journal-title":"J. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.lfs.2020.118048_bb0145","first-page":"90","article-title":"Activation of \u03bc-opioid receptors inhibits calcium-currents in the vestibular afferent neurons of the rat through a cAMP dependent","volume":"27","author":"Sese\u00f1","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.lfs.2020.118048_bb0150","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/MCG.0000000000001164","article-title":"Practical perspectives in the treatment of nausea and vomiting","volume":"53","author":"Cangemi","year":"2019","journal-title":"J. Clin. Gastroenterol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520307992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520307992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T21:20:38Z","timestamp":1765228838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520307992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":30,"alternative-id":["S0024320520307992"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118048","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventive effects of naldemedine, peripherally acting \u03bc-opioid receptor antagonist, on morphine-induced nausea and vomiting in ferrets","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118048"}}